
Ask a doctor about a prescription for LEVOBUPIVACAINE NORMON 0.625 mg/mL SOLUTION FOR INFUSION
Package Leaflet: Information for the User
Levobupivacaine Normon 0.625 mg/ml Solution for Infusion EFG
For Epidural Use Only
Levobupivacaine
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the Package Leaflet
Contents of the pack and further information.
Levobupivacaine Normon belongs to a group of medicines called local anesthetics. This type of medicine is used to numb parts of the body or to relieve pain.
Levobupivacaine Normon solution for infusion is only for use in adults.
Levobupivacaine Normon is used for the treatment of pain:
Do not use Levobupivacaine Normon:
Warnings and precautions
Talk to your doctor or nurse before you start using Levobupivacaine Normon. You may need closer monitoring or a lower dose.
Using Levobupivacaine Normon with other medicines
Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines. Tell them especially if you are taking medicines for:
Pregnancy, breastfeeding and fertility
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine.
Levobupivacaine Normon should not be given to relieve pain by injecting it into the area around the neck of the womb or cervix during childbirth (paracervical block).
The effects of Levobupivacaine Normon on the fetus during the first stages of pregnancy are not known. Therefore, Levobupivacaine Normon should not be used during the first three months of pregnancy unless your doctor considers it necessary.
It is not known if levobupivacaine passes into breast milk, however, based on experience with similar drugs, it is expected that only small amounts of levobupivacaine will pass into breast milk. Breastfeeding is therefore possible after using a local anesthetic.
Driving and using machines
Using Levobupivacaine Normon may have a considerable effect on your ability to drive or use machines. Do not drive or use machinery until the effects of Levobupivacaine Normon and the immediate effects of surgery have worn off. Make sure you are advised about this by your doctor or nurse before you leave the hospital.
Important information about some of the ingredients of Levobupivacaine Normon
This medicine contains 353.85 mg of sodium (main component of cooking/table salt) in each 100 ml bag. This is equivalent to 17.7% of the maximum recommended daily intake of sodium for an adult.
Your doctor will give you Levobupivacaine Normon through a small tube inserted into your back (epidural). Your doctor and nurse will carefully monitor you while you are being given Levobupivacaine Normon.
Dose
Adults:
The amount of Levobupivacaine Normon that you will be given and how often it will be given will depend on what it is being used for and your physical condition, age, and weight. You will be given the smallest dose that achieves anesthesia in the required area. The dose will be carefully chosen by your doctor.
When Levobupivacaine Normon is used to relieve pain during childbirth, the dose used will be carefully controlled.
Children:
Not recommended.
If you are given too much Levobupivacaine Normon
If you are given too much Levobupivacaine Normon, you may experience numbness of the tongue, dizziness, blurred vision, muscle twitching, severe difficulty breathing (including breathing stop), and even convulsions. If you notice any of these symptoms, tell your doctor immediately.
Sometimes too much Levobupivacaine Normon can also cause low blood pressure, slow heart rate or fast heart rate, and changes in your heart rhythm. Your doctor may need to give you other medicines to help stop these symptoms. If you have any other questions about the use of this medicine, ask your doctor or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you think you are experiencing any of the side effects listed below, tell your doctor or nurse immediately.
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Unknown: cannot be estimated from the available data
Other side effects that may occur:
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Unknown: cannot be estimated from the available data
Bradyarrhythmia, tachyarrhythmia, irregular heartbeat, and changes in heart rhythm that may be seen on an electrocardiogram (ECG) have also been reported as side effects.
In very rare cases, some side effects can become permanent.
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Vigilance System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of Levobupivacaine Normon
The active substance is levobupivacaine (as hydrochloride).
Levobupivacaine Normon 0.625 mg/ml solution for infusion: one milliliter contains 0.625 mg of levobupivacaine (as hydrochloride). Each bag contains 62.5 mg of levobupivacaine (as hydrochloride) in 100 ml.
The other ingredients are sodium chloride, sodium hydroxide, hydrochloric acid, and water for injections.
Appearance and packaging
Levobupivacaine Normon is a clear, colorless solution. It is available in 100 ml bags of solution for infusion ready for use. It is supplied in packs containing 24 bags.
Marketing authorization holder and manufacturer
LABORATORIOS NORMON S.A.
Ronda de Valdecarrizo, 6 - 28760 Tres Cantos- Madrid (SPAIN)
OTHER PRESENTATIONS
Levobupivacaine Normon 1.25 mg/ml solution for infusion EFG
Levobupivacaine Normon 2.5 mg/ml solution for injection and infusion EFG
Levobupivacaine Normon 5 mg/ml solution for injection and infusion EFG
Levobupivacaine Normon 7.5 mg/ml solution for injection and infusion EFG
This medicine is authorized in the Member States of the European Economic Area under the following names:
Spain: Levobupivacaine Normon 0.625 mg/ml solution for infusion EFG
Portugal: Levobupivacaine Normon 0.625 mg/ml solução para perfusão
Date of last revision of this leaflet: July 2021.
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
This information is intended only for healthcare professionals:
Levobupivacaine Normon 0.625 mg/ml solution for infusion EFG
Instructions for use and handling
Levobupivacaine Normon 0.625 mg/ml solution for infusion is for single use only and for epidural use only and should not be administered intravenously. Do not use unless the solution is clear and the packaging is intact. Discard any unused solution.
As with all parenteral medicines, the solution/dilution should be inspected visually prior to use. Only clear solutions without visible particles should be used.
Stability after dilution with a 0.9% sodium chloride solution:
Chemical and physical stability in use has been demonstrated for the dose of levobupivacaine 0.625 mg/ml with 8.3-8.4 micrograms/ml of clonidine, 50 micrograms/ml of morphine, and 2 micrograms/ml of fentanyl, stored for 30 days at 2-8°C or 20-22°C. Chemical and physical stability in use has been demonstrated for the dose of levobupivacaine 0.625 mg/ml with sufentanil added in a concentration of 0.4 micrograms/ml and stored for 30 days at 2-8°C or 7 days at 20-22°C.
From a microbiological point of view, the product should be used immediately. If not, the storage time and conditions of the product before use are the responsibility of the user and normally should not be more than 24 hours at 2-8°C, unless the mixture has been prepared in controlled and validated aseptic conditions.
Experience with the safety of levobupivacaine treatment for more than 24 hours is limited.
Levobupivacaine Normon should not be mixed with other medicines except those listed above. Dissolution with alkaline solutions such as sodium bicarbonate may cause precipitation.
Method of administration
Levobupivacaine should only be administered by a doctor who has the necessary training and experience or under their supervision.
For information on dosage, consult the Summary of Product Characteristics.
Careful aspiration should be performed before infusion to prevent intravascular injection. If toxic symptoms appear, the injection should be stopped immediately.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for LEVOBUPIVACAINE NORMON 0.625 mg/mL SOLUTION FOR INFUSION – subject to medical assessment and local rules.